L834-1060 Screening compound: N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide

L834-1060 Screening compound: N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide
L834-1060 Screening compound: N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L834-1060
N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L834-1060

Molecular Formula

C28H26N4O4 (C28 H26 N4 O4)

Compound Name

N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-2,2-diphenylacetamide

IUPAC name

N-{[3-(3-oxo-4-propyl-34-dihydro-2H-14-benzoxazin-6-yl)-124-oxadiazol-5-yl]methyl}-22-diphenylacetamide

SMILES

CCCN1c(cc(cc2)-c3noc(CNC(C(c4ccccc4)c4ccccc4)=O)n3)c2OCC1=O

InChI

InChI=1S/C28H26N4O4/c1-2-15-32-22-16-21(13-14-23(22)35-18-25(32)33)27-30-24(36-31-27)17-29-28(34)26(19-9-5-3-6-10-19)20-11-7-4-8-12-20/h3-14,16,26H,2,15,17-18H2,1H3,(H,29,34)

InChI Key

PZDVIEJDYYHXDS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478943

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.517

Distribution Coefficient, logD

4.517

Water Solubility, LogSw

-4.34

Polar Surface Area

79.803

Acid Dissociation Constant (pKa)

11.80

Base Dissociation Constant (pKb)

-0.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.40

L834-1060 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

DGK Inhibitors Library (10558 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L834-1060 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L834-1060?
Check Price and Availability of L834-1060, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L834-1060 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L834-1060
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L834-1060
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L834-1060 available by request